MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
Options positioning: Bearish — More betting on upside (1.3× more call than put volume today). Unusual bets on $46 downside — 11× normal activity. analysts: 23 buy vs 3 sell.
Novo Nordisk sees stock rise amid new Medicare program
Target: $45 avg (-28% upside)
23 Buy · 13 Hold · 3 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: Novo Nordisk's new access program for GLP-1s could significantly expand its market, presenting a strong growth opportunity.